using sbrt to delay systemic therapy for patients with oligometastatic rcc
Published 1 year ago • 165 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:48
combining radiotherapy and io for patients with oligometastatic rcc
-
2:41
stereotactic body radiotherapy and concomitant systemic therapy for oligoprogressive breast cancer
-
1:18
using radiotherapy to manage oligometastatic kidney cancer
-
2:49
recent advances in radiotherapy for oligometastatic disease
-
3:04
evaluating the role of radiotherapy in primary and metastatic rcc
-
9:59
evidence for local treatment of oligometastatic disease
-
1:14:16
rcc sbrt/srs 2.0 session 10: hypofractionation clinical applications | dr. robert timmerman
-
9:40
new trends in sbrt for kidney cancer
-
2:50
the role of cytoreductive nephrectomy and metastasectomy in renal cell carcinoma
-
5:45
the case for sbrt as renal cell carcinoma treatment
-
45:30
liver stereotactic body radiotherapy (sbrt): primary and oligometastatic by joseph herman, md
-
2:20
sbrt for oligometastatic lung cancer
-
24:53
systemic treatment options for patients with metastatic non-clear cell renal cell carcinoma
-
9:57
oligometastatic renal cell carcinoma
-
2:33
the use of single-fraction sbrt versus multi-fraction sbrt for lung cancers and metastases
-
1:15:33
arro visiting professor seminar series: sabr for primary renal cell carcinoma
-
4:02
stereotactic body radiotherapy (sbrt) in nsclc
-
5:25
dr. zengin on sbrt utilization in oligoprogressive, metastatic rcc
-
1:39
the impact of time-to-treatment on sbrt outcomes